InvestorsHub Logo
Followers 63
Posts 9080
Boards Moderated 1
Alias Born 10/06/2003

Re: plutoniumimplosion post# 45978

Wednesday, 07/12/2017 1:32:27 PM

Wednesday, July 12, 2017 1:32:27 PM

Post# of 97077
Sure, no problem.....Emphasis in red.

The new GenStrip commercial will be played in many metropolitan areas beginning January 15, 2014 and running through the upcoming Winter Olympics and beyond. Time has been booked from 1:00 pm through 6:00 pm for all days of Olympics telecasts. In addition, the company has booked over 10,000 commercial plays during late night hours, where successful diabetes suppliers have dominated in the past.

https://finance.yahoo.com/news/decision-diagnostics-announces-posting-airing-141500766.html

Keith Berman, CFO of InstaCare Corp. commented, "Our concept of offering medical legacy system applications that conform to the latest EMR/HER standards and that run on cell phones, support our seminal belief that our MD@Hand and MD@Work are game changing products. Now that the healthcare market indecision is in the past, and with our full utility patent application on file, and additional continuation in part applications forthcoming, we will shortly publish a study completed in 2010 and recently updated, to provide our shareholders and the investment community with a third party evaluation of the potential economic value of our technologies. This study is a major part of our previously stated initiative to achieve a listing on the NYSE-Amex."

http://www.biocompare.com/Life-Science-News/85286-InstaCare-Files-Full-Utility-Patent-For-MD-Hand-MD-Work-Technologies/

"As soon as the media company produces the complete media schedule, we will post this schedule on our Web Sites"

https://www.accesswire.com/409154/Well-Ahead-of-Schedule-Decision-Diagnostics-Pharma-Tech-Division-Completes-First-Major-Shipments-of-its-Popular-Genstrip-Test-Strip

Keith Berman, Principal Executive Officer and CFO stated: "As we have repeatedly stated during this lengthy process, J&J/Lifescan will not be readily released from its legal and financial obligations stemming from its onerous actions against our product and company. A modest level of compensation will not rectify the considerable damages that they have inflicted. Our positions will be vindicated, our product fully restored and our shareholders rewarded for their patience. No company, regardless of their size, wealth or power, can willfully ignore all legal and ethical business practices. We will prevail and will be awarded appropriate reparations for our sustained damages."

http://www.marketwired.com/press-release/decision-diagnostics-rejects-settlement-offers-from-j-j-lifescan-companys-prosecutions-otc-pink-decn-1997441.htm

Mr. Berman continued, "We are energized and reborn. Wasted years, lost opportunity and unnecessary expense are now behind us. We have won so conclusively that the Federal Circuit Court took the uncommon step of awarding us court costs in their Rule 36 decision. That award punctuated their decision and emphasized their conviction in the ruling. We would like to thank all of our shareholders who have supported our efforts and fought the battle with us. We are fully committed to shortly rewarding their patience, investment and encouragement."
http://www.marketwired.com/press-release/decision-diagnostics-conveys-opportunities-potential-following-landmark-circuit-court-otc-pink-decn-2095138.htm


"We are now fully current with our reporting and are anxious to forge forward. Filing an application to uplist for trading on OTCQX is the next step of financial reporting progression and the wider quoting of our securities."

and.....

Mr. Berman concluded, "At the close of the review of our OTCQX application, DECN will host a conference call to inform our shareholders and others in the investment community of the company's progress and our plans for the near future. The summer portends an exciting period of growth, promise and success for the company."

http://www.biospace.com/news/decision-diagnostics-files-application-for/376938

"....allow us to streamline our capital structure and apply for a national listing for our common stock. This listing will significantly enhance the visibility of our stock for investors and drive increased liquidity. We are excited to announce these important efforts today."

http://www.prnewswire.com/news-releases/instacare-changes-name-to-decision-diagnostics-corp-will-apply-for-nasdaq-bx-exchange-listing-134823668.html